Corrigendum to: A randomized phase III study comparing trastuzumab emtansine with trastuzumab, pertuzumab and docetaxel in elderly patients with advanced stage HER2-positive breast cancer: Japan Clinical Oncology Group Study (JCOG1607, HERB TEA study)

In the originally published version of this manuscript, the title and a citation was incorrect.
Source: Japanese Journal of Clinical Oncology - Category: Cancer & Oncology Source Type: research